The Effect of Ultrasound-guided Ilioinguinal and Iliohypogastric Nerve Block on Catheter-related Bladder Discomfort in Patients undergoing TURP

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2300078552

Enrollment

Unknown

Registered

2023-12-12

Start date

2023-12-15

Completion date

Unknown

Last updated

2023-12-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prostatic hyperplasia

Interventions

Ilioinguinal and iliohypogastric nerve block group (TAP group):Ultrasould-guided ilioinguinal and iliohypogastric nerve block

Intravenous tramadol group (TI group):Intravenous administration of tramadol (1.5mg/kg)

Eligibility

Sex/Gender

Male

Age

45 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1: Age 45-75 years old 2: Requirement of three-cavity catheter (F20) placement after surgery 3: ASA I or II level 4: BMI 18-28kg/m2 5: Operation duration < 120min

Exclusion criteria

Exclusion criteria: 1: Severe cardiac dysfunction 2: End-stage renal disease 3: Neurological diseases 4: Previous or current catheter placemen 5: Medical history of allergy to tramadol 6: Bladder dysfunction 7: Previous penile or prostate surgery 8: Refuse to participate in the trial

Design outcomes

Primary

Measure	Time frame
The occurance of CRBD;	—

Secondary

Measure	Time frame
The extent of CRBD;The extent of pain;The frequency of tramadol and flurbiprofen axetil;Adverse events;Complications related to nerve block;Patient satisfaction with anesthesia method;Clinical outcomes;	—

Countries

China

Contacts

Public ContactLiangrong Wang

The First Affiliated Hospital of Wenzhou Medical University

arerong1984@126.com+86 135 8788 4540

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026